FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "Composition",
  "id": "COVID19IntensiveCareTreatmentGuideline",
  "meta": {
    "profile": [
      "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/guideline"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "RI",
            "display": "Resource identifier"
          }
        ]
      },
      "system": "https://www.awmf.org/",
      "value": "113-001"
    }
  ],
  "version": "7.0",
  "status": "final",
  "type": {
    "coding": [
      {
        "system": "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/ceosys-code-system",
        "code": "clinical-practice-guideline"
      },
      {
        "system": "https://data.cochrane.org/concepts/",
        "code": "e07eN1w1Rwswg4",
        "display": "Guidelines"
      }
    ]
  },
  "category": [
    {
      "coding": [
        {
          "system": "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-guideline-stage-classification",
          "code": "S3",
          "display": "Evidence- and consensus-based guideline"
        }
      ]
    }
  ],
  "date": "2022-03-01",
  "author": [
    {
      "reference": "Organization/AWMFOrganization"
    }
  ],
  "title": "Empfehlungen zur stationären Therapie von Patienten mit COVID-19 - Living Guideline",
  "relatesTo": [
    {
      "type": "citation",
      "resourceReference": {
        "reference": "Citation/COVID19IntensiveCareTreatmentGuidelineCitation"
      }
    }
  ],
  "section": [
    {
      "title": "Stationäre Therapie von COVID-19 Patienten",
      "code": {
        "coding": [
          {
            "system": "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/ceosys-code-system",
            "code": "guideline-recommendation",
            "display": "Clinical practice guideline recommendation"
          }
        ]
      },
      "focus": {
        "reference": "PlanDefinition/COVID19VentilatedPatientsDexamethasoneApplicationPlan"
      },
      "text": {
        "status": "generated",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><strong>Systemische Steroide:</strong> Bei Patienten mit COVID-19- und Sauerstoff-Bedarf (Niedrigfluss-Sauerstoff-Insufflation, High-Flow Nasal Cannula, Nichtinvasive Beatmung/CPAP, invasive Beatmung) soll eine Therapie mit systemischen Kortikosteroiden erfolgen. Die Therapie sollte mit 6 mg Dexamethason p.o. oder i.v. über zehn Tage erfolgen.</div>"
      }
    },
    {
      "title": "Stationäre Therapie von COVID-19 Patienten",
      "code": {
        "coding": [
          {
            "system": "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/ceosys-code-system",
            "code": "guideline-recommendation",
            "display": "Clinical practice guideline recommendation"
          }
        ]
      },
      "focus": {
        "reference": "PlanDefinition/COVID19NonVentilatedPatientsDexamethasoneApplicationPlan"
      },
      "text": {
        "status": "generated",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><strong>Systemische Steroide:</strong> Bei Patienten mit moderater Erkrankung (hospitalisiert ohne Notwendigkeit von Niedrigfluss-Sauerstoff-Insufflation) soll keine Therapie mit systemischen Kortikosteroiden erfolgen.</div>"
      }
    }
  ]
}